Description
AM630 is a CB2 receptor antagonist. It is selective for CB2 over the CB1 receptor. AM630 activates TRPA1 in sensory neurons. This activation increases the hyperalgesic effect from capsaicin-induced pain models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
AM630 is a CB2 receptor antagonist. It is selective for CB2 over the CB1 receptor. AM630 activates TRPA1 in sensory neurons. This activation increases the hyperalgesic effect from capsaicin-induced pain models.
| Cas No. | 164178-33-0 |
|---|---|
| Purity | ≥97% |
| Formula | C23H25IN2O3 |
| Formula Wt. | 504.37 |
| Chemical Name | 6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone |
| IUPAC Name | [6-iodo-2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]-(4-methoxyphenyl)methanone |
| Synonym | AM 630, Iodopravadoline |
| Solubility | 100mM in DMSO |
| Appearance | White to off-white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Ross RA, Brockie HC, Stevenson LA, et al. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630. Br J Pharmacol. 1999 Feb;126(3):665-72. PMID: 10188977
Patil M, Patwardhan A, Salas MM, et al. Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons. Neuropharmacology, 2011 Sep;61(4):778-88. PMID: 21645531.
Btk inhibitor.
Taxane found in Taxus; microtubule depolymeriza...
Aminocoumarin; bacterial DNA gyrase inhibitor.<...
Aromatic retinoid; RAR, RXR agonist.
Benzazepine derivative; D1 partial agonist, pot...
Broad-spectrum antibiotic
SGLT2 inhibitor
Alkylphospholipid analog; Akt inhibitor.
Prevents MHC II antigen presentation.
HIV protease inhibitor, SERCA inhibitor.
MET inhibitor.
Phthalide; PPARγ agonist, IMPDH inhibitor, mic...
Isoflavone found in soy; SERM.
Cyclic depsipeptide is a secondary metabolite i...
Triterpene saponin found in species of Panax.
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...
NSAID; COX-1/2 inhibitor.
JAK2 inhibitor.
Selective Cannabinoid receptor 2(CB2) inverse a...